Patients with impaired kidney function. Risk of soft tissue calcification should be account. Severe kidney insufficiencies. Patients with a tendency of kidney stone which contains calcium. Patients receiving cardiovascular medication, ie. cardiac glycosides. Sarcoidosis. The use of vitamin D preparations in the treatment of hyperparathyroidism associated with cardiovascular disease is not recommended, as it may lead to kidney failure. Pregnancy, lactation.